Navigation Links
Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
Date:2/6/2008

BOSTON, Feb. 6 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50% in recent years.

According to the new 160-plus page report from CenterWatch entitled, Asia- Pacific's Growing Role in Global Clinical Trials, Asia Pacific countries are tapping into their power as a bloc to boost their role in the expanding global clinical trials market.

An important part of the report contains the results from CenterWatch's first-ever survey of clinical researchers in the region. CenterWatch surveyed more than 156 investigative sites from more than a dozen countries in Asia Pacific. The survey revealed, among other results, the key role of electronic data capture (EDC) of clinical trial information in this region.
Highlights of this report include:

* Charts of survey results from CenterWatch's ground-breaking investigator

survey of the region. Fifty charts with proprietary data are included.

* A pipeline of drugs in development in Asia-Pacific countries.

* Extensive interviews with executives from global pharmaceutical

companies and contract research organizations (CRO) who have on-the-

ground experience in the Asia-Pacific region.

* A breakdown of contract research organizations country-by-country.

The global CRO market has been a great worldwide growth story and the Asia-Pacific region has been one of the hottest areas for this growth. 2007 saw more CRO mergers and acquisitions--35--than in any previous year since CenterWatch began tracking the market in the mid 1990s when contract research took off.

"More than half of those acquisitions were made to take advantage of the growth in global clinical trials
'/>"/>

SOURCE CenterWatch
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
4. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
5. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
6. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
7. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
10. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Texas , Nov. 21, 2014  World Hemp ... containing low THC, announces they are now offering legal, ... to Charlotte,s Web type strains grown in medical marijuana ... other neurological disorders, such as Parkinson,s, MS, and spinal ... US laws to pass, because imported CBD Oil Is ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
(Date:11/21/2014)... Nov. 20, 2014  Market research firm Kalorama information says ... The Buy, in the medical device industry.  The firm ... will produce just 3% growth this year, which led ... of product lines and entrance by acquisition into new ... medical devices, The Global Market for Medical Devices, ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2
... HONG KONG, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, ... acquire the remaining interests in the Group,s Chinese ... HK$90 million in shares.  Upon completion of the ...
... Calif., Feb. 24, 2011 Amgen (Nasdaq: AMGN ... 3 head-to-head trial that compared XGEVA ™ (denosumab) to ... skeletal-related events (SREs) in 1,901 men with prostate cancer and ... met its primary and secondary endpoints and demonstrated XGEVA,s superiority ...
Cached Medicine Technology:Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 2Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 3Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 4Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 5Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 6Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 7Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 8Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer 9
(Date:11/22/2014)... NC (PRWEB) November 23, 2014 Cancer ... found a connection between intercellular communication tunnels and the ... read the full story on the Surviving Mesothelioma ... Center and the University of Minnesota have just released ... carry information and materials between cells. They found that ...
(Date:11/22/2014)... A classic black prom dress will never go ... suppliers, has unveiled its new items of black prom ... at a big discount, up to 70% off. People throughout ... new black prom dresses, made with the best materials, can ... of all customers, the company provides these beautiful outfits in ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... "My friend went in for a mammogram ... said an inventor from Cambria Heights, N.Y. "To add ... second time because the first results were inaccurate. Her ... patent-pending MAMO EASY to offer a more comfortable way ... patient from the pain normally involved with this procedure. ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2
... Storage and to Advance VSEL Research, NEW YORK, ... is pioneering the pre-disease collection, processing and long-term,storage of ... that,it has signed a collection center agreement with the ... Robin Smith, MD MBA, NeoStem,s Chairman and Chief Executive ...
... May 27 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ... dollars from Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ... the recently announced transaction,between Takeda Pharmaceutical Company Limited ... receive portions of future milestone and royalty,payments. This ...
... communities save time and money accepting automatic ... payments direct from resident bank accounts, PORTLAND, ... it,has added PaySimple, the leading provider of on-demand ... to help simplify resident billing,and collection for assisted ...
... join the Urban League of,Philadelphia for FREE Open House Clinics ... ages 19 and under, in,Pennsylvania,s Children,s Health Insurance Program (CHIP). ... the Urban League of Philadelphia, 121,S. Broad Street (between Chestnut ... Wednesday, May 28th, 6pm - 8pm Wednesday, ...
... at UCLA have identified a type of leukemia stem cell ... normal blood stem cells to become cancerous. , The discovery ... cells, attacking the disease at its very root and killing ... cells. The study appears in the May 22, 2008 issue ...
... Inc. (Nasdaq: EVVV ) today,announced that Robert Palmisano, ... the Goldman Sachs Twenty-Ninth Annual Global,Healthcare Conference on Tuesday, ... and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual ... Niguel in,Dana Point, California., To access the webcast, ...
Cached Medicine News:Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 2Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3Health News:Vigilan Offers PaySimple to Simplify Resident Billing and Collection 2Health News:Does Your Child Have Health Insurance? Urban League of Philadelphia Announces Free Open Houses for CHIP Enrollment 2Health News:UCLA researchers identify leukemia stem cells 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: